These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 1865658

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [The mechanisms of disorders in the hemostatic system of patients with chronic diffuse liver diseases].
    Podymova SD, Serov NA, Serov VA, Sukhanov VA, Brodskaia IK.
    Ter Arkh; 1990; 62(2):72-6. PubMed ID: 2336628
    [Abstract] [Full Text] [Related]

  • 3. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
    Koruk M, Onuk MD, Akçay F, Savas MC.
    Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
    [Abstract] [Full Text] [Related]

  • 4. Hemostasis and global fibrinolytic capacity in chronic liver disease.
    Aytac S, Turkay C, Bavbek N, Kosar A.
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):623-6. PubMed ID: 17890949
    [Abstract] [Full Text] [Related]

  • 5. [Regulators of fibrinolysis in chronic viral pathology of the liver].
    Iagoda AV, Koroĭ PV.
    Ter Arkh; 2009 Oct; 81(2):50-4. PubMed ID: 19334490
    [Abstract] [Full Text] [Related]

  • 6. [The significance of sIL-2R detection in various hepatic diseases].
    Xuan SY, Jiang LM, Lu WH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Apr; 18(2):92-4. PubMed ID: 9812507
    [Abstract] [Full Text] [Related]

  • 7. Low levels of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with chronic liver disease.
    Van Thiel DH, George M, Fareed J.
    Thromb Haemost; 2001 Apr; 85(4):667-70. PubMed ID: 11341503
    [Abstract] [Full Text] [Related]

  • 8. [Porphyrin biosynthesis in patients with acute viral hepatitis, chronic hepatitis and liver cirrhosis].
    Pisanets MP, Alagezian DS.
    Klin Med (Mosk); 1987 Sep; 65(9):76-8. PubMed ID: 3695317
    [No Abstract] [Full Text] [Related]

  • 9. [Detection of serum free insulin-like growth factor 1 in patients with chronic viral hepatitis].
    Lou M, Song N, Jin X, Luo SQ, Wang JJ.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):291-2. PubMed ID: 11986710
    [Abstract] [Full Text] [Related]

  • 10. The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? Yes.
    Basili S, Raparelli V, Violi F.
    Eur J Intern Med; 2010 Apr; 21(2):62-4. PubMed ID: 20206871
    [Abstract] [Full Text] [Related]

  • 11. The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? No.
    Tripodi A.
    Eur J Intern Med; 2010 Apr; 21(2):65-9. PubMed ID: 20206872
    [No Abstract] [Full Text] [Related]

  • 12. [The behavior of lipids in acute viral hepatitis and chronic hepatopathies].
    Boroń-Kaczmarska A, Lapiński W.
    Z Gesamte Inn Med; 1988 May 01; 43(9):225-8. PubMed ID: 3136599
    [Abstract] [Full Text] [Related]

  • 13. [ABO and RH-HR blood-group systems in acute and chronic liver diseases].
    Sowa J, Odrobina S.
    Przegl Lek; 1982 Sep 01; 39(8):547-50. PubMed ID: 6813916
    [No Abstract] [Full Text] [Related]

  • 14. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis.
    Kuper H, Ye W, Broomé U, Romelsjö A, Mucci LA, Ekbom A, Adami HO, Trichopoulos D, Nyrén O.
    Hepatology; 2001 Oct 01; 34(4 Pt 1):714-8. PubMed ID: 11584367
    [Abstract] [Full Text] [Related]

  • 15. Sulphur amino acid pattern in chronic liver disease.
    Almasio P, Bianchi G, Marchesini G, Luca A, Bugianesi E, Le Grazie C, Pagliaro L.
    Ital J Gastroenterol; 1994 Oct 01; 26(1):21-5. PubMed ID: 8025302
    [Abstract] [Full Text] [Related]

  • 16. [Changes in fibrinolysis in liver cirrhosis].
    Fontcuberta J, Borrell M, Felez J, Elez I, López M, Remacha A, Rutllant ML.
    Sangre (Barc); 1982 Oct 01; 27(4-B):727-36. PubMed ID: 6186038
    [No Abstract] [Full Text] [Related]

  • 17. [Use of serological markers in the diagnosis and prognosis of chronic viral hepatitis].
    Valdovinos Díaz MA, Páez Rodríguez O, Galván Guerra E, Wolpert E.
    Rev Invest Clin; 1985 Oct 01; 37(4):373-83. PubMed ID: 3006201
    [No Abstract] [Full Text] [Related]

  • 18. [Disorders of coagulation/fibrinolysis and bleeding tendency].
    Endo T, Amemiya N, Kume S.
    Nihon Rinsho; 1994 Jan 01; 52(1):119-23. PubMed ID: 8114280
    [Abstract] [Full Text] [Related]

  • 19. [Studies of fibrinolytic activity and disseminated intravascular coagulation in chronic hepatitis and liver cirrhosis].
    Kleinstein I, Dascălu M, Ababei V, Jurebiţă L.
    Rev Med Chir Soc Med Nat Iasi; 1972 Jan 01; 76(2):311-8. PubMed ID: 4262684
    [No Abstract] [Full Text] [Related]

  • 20. [Hemostatic changes in the course of different chronic hepatopathies].
    Ruggiero G, De Biasi R, Lembo N, Giusti G.
    Minerva Med; 1975 Feb 21; 66(13):595-601. PubMed ID: 1113909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.